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Fecal microbiota transplantation restores
dysbiosis in patients with methicillin
resistant Staphylococcus aureus enterocolitis
Yao Wei, Jianfeng Gong*, Weiming Zhu, Dong Guo, Lili Gu, Ning Li* and Jieshou Li
Abstract
Background: Nosocomial Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is rare but can be fatal unless
it is detected at an early stage and treated effectively. Dysbiosis of the gut is one of the leading reasons of MRSA
enteritis. Fecal microbiota transplantation (FMT) is a burgeoning treatment to rectify this imbalance. But the impact
of FMT on MRSA enterocoitis is still unknown yet.
Methods: A total of 5 patients diagnosed as MRSA enteritis during the early postoperative period were given
vancomycin 2 g/day for 3 days and FMT for three continuous days as a standard treatment.
Result: There was a 100 % clinical response rate that all the symptoms resulting from MRSA enterocolitis disappeared
and MRSA in the feces eliminated clearly. The microbiota profile in feces of the patients also regained balance.
Conclusion: FMT can be a preferential measure to restore the dysbiosis caused by MSRA enterocolitis.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
one of the major sources of nosocomial infection.
Along with the widely application of antibiotics around
perioperative period, MRSA infection is increasing by
years. People are the natural reservoir of MRSA but its
growth and reproduction is limited by other intestinal
flora [1], rarely cause enteritis. Enterocolitis caused by
MRSA was first reported in Europe in 1961 and then
investigators in Australia, Japan and France have reported
MRSA as a cause of antibiotic-associated diarrhea among
hospitalized patients, but all of the reported cases were
treated by vancomycin only and had no data about the
changes of the gut flora [2].
Fecal microbial transplantation (FMT),infusion of
fecal preparation from a healthy donor into the GI tract of
a patient is being proposed as a novel therapeutic approach
to modulate diseases associated with pathological imbal-
ances within the resident microbiota, termed dysbiosis [3].
It has been used to treat intestinal disease such as inflam-
matory bowel diseases and Clostridium difficile infection,
but no reports are available on its role in treating
MRSA enteritis yet. Here we reported five cases of MSRA
enterocolitis cured by fecal microbiota transplantation
(FMT) combined with vancomycin. For the first time, we




This study was approved by the Institutional Ethics
Committee of Jinglin hosipital. Five cases from July,
2013 to February, 2014 were collected in Jinling hospital.
Written informed consent was obtained from all the
patients and the donors. There were three males and
two females with an age range from19–45 years (mean
age, 28 years) (Table 1). No patients were on proton
pump inhibitors (PPI) or had a history of MRSA prior to
operation. Antibiotics given at induction and continued
in the postoperative period were showed in detail
(Table 2). The patients were placed on the open ward
prior to development of symptoms.
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All the patients developed unexplained high fever
(over 39°), bloating, nausea, vomit, a high stoma output
or diarrhea in the color of yellow-green with copious
amounts of mucus leading to dehydration and tachycardia
after short time of operation (2-4d). Full septic screen was
performed. This included bacterial swabs of stoma as well
as blood, urine, ascites and gastric juice cultures. These
were repeated throughout the diseased state. Fecal was
investigated for Salmonella spp. and Clostridia difficile.
Radiological studies included plain radiographs, ultra-
sonography, contrast computerized tomography (CT)
to exclude intraabdominal or other infections. We got
the etiology diagnosis from all the ptients’ gastric juice
cultures which revealed MRSA and collected MRSA
strain for further genotype identification. One patient
(Patient 2) also underwent colonoscopy correspondingly
showed mucosal edema and large quantity of pseudomem-
brane (Fig. 1).
Donor
The intended stool donors had received no antibiotic
therapy within the last 6 months. To avoid a transmission
of other diseases, donors had to have a negative history
for intestinal diseases or recent gastrointestinal infections,
autoimmune or other immune-mediated diseases, or any
kind of malignancies. Chronic hepatitis B and C, human
immunodeficiency virus, and syphilis were excluded and
the donors’ stool was tested for C. difficile, enterohemor-
rhagic Escherichia coli, Salmonella, Shigella, Yersinia, and
Campylobacter as well as parasites. Stool samples of four
donors were collected for further analysis of the fecal
microbiota, unfortunately we lost a sample stool from one
donor.
Donor material preparation
Donors produced stool samples within 6 h before FMT.
60 g fresh fecal samples were blended with 350 ml sterile
saline for 10 min in a designated GI laboratory space. This
blended fecal mixture was then filtered through 3 gauze
pieces to remove larger sediments. Filtered fecal preparation
was then kept at 4 °C until FMT was performed.
Transplantation procedure
All patients had been informed and agreed to undergo
FMT. All but one (who accepted vancomycin for 10 days
before FMT) were maintained on full dose of vancomycin
(Vancocin cp) (500 mg, twice a day for continuous three
days) until 12 h before the FMT procedure. The prepared
donor microbiota was administered via nasojejunal tube
once a day for 3 consecutive days (Table 3). Since the
patients all suffered from severe diarrhea, no mechanical
Table 1 Basic clinical data of the patients
Patient Underlying pathology Operations Ileostomy Onset of disease after surgery
Patient 1 Crohn’s disease The terminal ileum enterostomy YES 2 days
Patient 2 pancreatic cancer Whipple Procedure + Percutaneous jejunostomy NO 4 days
Patient 3 Crohn’s disease The terminal ileum enterostomy YES 2 days
Patient 4 congenital intestinal malrotation Volvulus reduction + Gastrostomy NO 3 days
Patient 5 Crohn’s disease The terminal ileum enterostomy YES 4 days
Table 2 Drugs given at induction and continued in the postoperative period
patients Name of drug dose Manufacturer
Patient 1 Vancomycin (Vancocin cp) 0.5 g q12h for 10 days Eli Lilly and Company
Patient 2 Cefuroxime (Zinacef) 1.5 g 2 h before operation
and 48 h after operation
Glaxo Wellcome Op
Ornidazole (TUOSU) 0.5 g 2 h before operation
and 48 h after operation
Sichuang Kelun Pharmaceutical Co. Ltd
Pantoprazole (TIANLONG) 40 mg 48 h after operation Liaoning Tianlong Pharmaceutical Co. Ltd
Patient 3 Ceftriaxone sodium Tazobactam
sodium (YOUTANENG)
2 g 2 h before operation
and 48 h after operation
Haikou Qili Pharmaceutical Co. Ltd
Omeprazole (AOXIKANG) 40 mg 48 h after operation Jiangsu Aosaikang Pharmaceutical Co. Ltd
Patient 4 Ceftriaxone sodium Tazobactam
sodium (YOUTANENG)
2 g 2 h before operation
and 36 h after operation
Haikou Qili Pharmaceutical Co. Ltd
Omeprazole (AOXIKANG) 40 mg 72 h after operation Jiangsu Aosaikang Pharmaceutical Co. Ltd
Patient 5 ceftazidime (Fortum) 2 g 2 h before operation
and 72 h after operation
GlaxoSmithKline plc
Pantoprazole (Pantoloc) 40 mg 48 h after operation Nycomed GmbH
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Fig. 1 Patient 2's colonoscopy before and after treatment. a. showed mucosal edema and large quantity of pseudomembrane in the colon
before FMT and vancomycin. b. the pseudomembrane disappeared and mucosa healed well after the treatment of FMT combined with
vancomycin for three days. FMT = fecal microbiota transplantation
Table 3 Data of fecal mircobiota transplantation
Patients Donor Transplantation time Transplanted stool weight Transplantation way Drug before transplantation
Patient 1 Unrelated Child (6 year) One time a day for
continuous three days
60 g every time nasointestinal tube Vancomycin※
0.5 g,q12h for continuous
10 days
Patient 2 Her son (25 year) One time a day for
continuous three days
60 g every time Jejunostomy fistula tube Vancomycin※
0.5 g,q12h for continuous
three days
Patient 3 Unrelated Healthy
girl (23 year)
One time a day for
continuous three days
60 g every time nasointestinal tube Vancomycin※
0.5 g,q12h for continuous
three days
Patient 4 His mother (43 year) One time a day for
continuous three days
60 g every time Gastrostomy fistula tube Vancomycin※
0.5 g,q12h for continuous
three days
Patient 5 His mother (49 year) One time a day for
continuous three days
60 g every time nasointestinal tube Vancomycin※
0.5 g,q12h for continuous
three days
※ Made in Eli Lilly and Company, Trade name is Vancocin cp







Begin to use enteral nutrition
(days after the enteritis onset)
MRSA screen
Patient 1 40.1 6970/1510 9814/1666 3 days gastric juice
Patient 2 39.5 10840/380 10225/1230 4 days gastric juice, abdominal
drainage fluid
Patient 3 39.3 5521/2870 9800/2580 3 days gastric juice, ascitic fluid
Patient 4 39.5 4909/770 5486/1150 2 days gastric juice, sputum
Patient 5 40.2 3890/1275 7202/1905 2 days gastric juice, ileum
colostomy liquid
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bowel preparation were done prior to FMT as usually
recommended [4].
Microbial diversity and type of MRSA analysis
Microbial diversity analysis
Microbial DNA was extracted from fecal samples using
the E.Z.N.A. ® DNA Kit (Omega Bio-tek, Norcross,
GA, U.S.) according to manufacturer’s protocols. The
V4-V5 region of the bacteria 16S ribosomal RNA gene were
amplified by PCR (95 °C for 2 min, followed by 25 cycles at
95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s and
a final extension at 72 °C for 5 min) using primers 515 F
5’-barcode- GTGCCAGCMGCCGCGG)-3’ and 907R
5’-CCGTCAATTCMTTTRAGTTT-3’, where barcode
is an eight-base sequence unique to each sample. PCR
reactions were performed in triplicate 20 μL mixture
containing 4 μL of 5 × FastPfu Buffer, 2 μL of 2.5 mM
dNTPs, 0.8 μL of each primer (5 μM), 0.4 μL of FastPfu
Polymerase, and 10 ng of template DNA. Amplicons were
extracted from 2 % agarose gels and purified using the
Fig. 2 Changes of the flora throughout the course of the disease. D = donor. BF = before fecal microbiota transplantation. AF-1 = one day after
fecal microbiota transplantation. AF-3 = three days after fecal microbiota transplantation. AF-5 = five days after fecal microbiota transplantation.
AF-7 = seven days after fecal microbiota transplantation. Different colors represent different species
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AxyPrep DNA Gel Extraction Kit (Axygen Biosciences,
Union City, CA, U.S.) according to the manufacturer’s
instructions and quantified using QuantiFluor™ -ST
(Promega, U.S.). Purified amplicons were pooled in
equimolar and paired-end sequenced (2 × 250) on an
Illumina MiSeq platform according to the standard
protocols. The raw reads were deposited into the
NCBI Sequence Read Archive (SRA) database.
Type of MRSA analysis
DNA were extracted from different specimens.9 primers of
SCCmecI-V were synthesized with multiple PCR technique
according to the reference [5] and for STR analysis to
make out the type of MRSA.
Results
Clinical outcome
All the patients’ MRSA enteritis was cured showing
no symptoms resulting from MRSA enterocolitis.
Continuous renal replacement therapy (CRRT) was
performed in all patients due to severe SIRS response,
and they returned to normal temperature in 2–3 days.
Mean maximum stoma or stool output decreased
from6426.00 ± 2707.90 ml to 1361.00 ± 951.09 ml and
the mean daily fluid requirements decreased from
8505.40 ± 2071.30 ml to1706.20 ± 578.96 ml within
10 days after disease onset (Table 4). Besides, all the
patients can use enteral nutrition every well without
problem. They were followed up for 3 months with
repeated stool culture, which all showed negative for
MRSA.
Changes of the gut microbiota before and after FMT
In order to detect the effect of FMT for MSRA enteritis,
we collected the stool or ileostomy fluid of patients
before and after FMT and stool of the donors to
analyze the changes of flora (Fig. 2). We can clearly find
from the flora analysis results that all the patients had a
decreased intestinal flora species before FMT and the
content of staphylococcus aureus almost reached half of
total intestinal flora in all patients before transplant-
ation which is consistent with the clinical symptom
and examination results. Patients’ gut bacteria after FMT
gradually agree with the donors’ reflected the alleviative
symptoms.
Staphylococcal Cassette Chromosome mec (SCCmec)
Genotype
Totally 6 non-duplicated clinical strains of S. aureus
isolates from ascites, gastric juice, sputum, ileostomy
fluid and feces of the five patients were collected.
The genotypes of SCCmec were determined by multiplex
PCR. According to the results of STR parting, the length
of SCCmec gene amplification in the sample is 398
and make sure that the epidemic strain of this hospital
acquired MRSA is SCCmec type II (Figs. 3, 4, 5).
Discussions
The incidence of antibiotic associated diarrhea is increasing
dramatically. About 3 % to 29 % of hospitalized patients
suffered from it [6]. Scopetti et al. [2] first reported acute
enteritis caused by MRSA in 1983. Symptoms of
MSRA enteritis usually appear 2 to 7 days after surgery.
Patients with delayed clinical symptoms often have normal
Fig. 3 Polymerase Chain Reaction result of Staphylococcal Cassette Chromosome mec gene
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Fig. 4 Staphylococcal Cassette Chromosome mec Genotype showed the strain of the acquired MRSA is SCC mec typeII as the amplification
length are all 398 bp
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gastrointestinal peristalsis, leading to fewer toxins within
the lumen. MRSA enteritis is characterized clinically
by an acute onset in the early postoperative phase of
fever, abdominal distension and production of a frothy,
brownish-green, mucous watery effluent. The resulting sys-
temic inflammatory response syndrome is associated with
a high ileostomy output and related sepsis which can lead
to severe dehydration, shock and eventually multi-organ
failure even, in some circumstances, death [5, 7, 8].
The human intestine harbors abundant microbiota,
which plays crucial roles in our healthy. One important
function of it is acting as a barrier against pathogen
colonization or overgrowth of resident opportunistic
bacteria like MRSA [9]. These processes are made
possible when the presence of abundant and diverse
microbiota [10]. Disturbances of the microbiota caused by
antibiotics have profound effect on its composition and
function. But even the normal dose, with indications of
anti-infection treatment may result in patients with
intestinal flora disturbance like our patients with
Crohn's disease because they have a vulnerable intestinal
micro ecology and abnormal immune function. In our
microbial diversity analysis we found that all the patients
had a very low level diversity of the microbiota and S.
aureusis account for more than half of it. That means
sever dysbiosis in the gut leading to sparing MRSA
multiply. Compared with MSRA enteritis, enteritis
caused by Clostridium difficile is more concerned in
recent years. This infection is easy to recur and gradually
develop resistance to vancomycin. Therefore, fecal bacteria
transplantation as the treatment of repeated recurrence
CDI has been put forward and obtained excellent curative
effect [4]. One of the basic theories of this treatment
is intestinal dysbiosis.
The first patient showed up severe diarrhea and hyper-
pyrexia needing more than 10 L fluid each day at the very
start and we had no idea about the reasons, so we use
spectrum antibiotic empirically. But it had a poor effect.
When we got the result of gastric juice culture telling us a
MRSA, we quickly employed Vancocin cp but only find a
dissatisfied effect again. Therefore, we tried FMT to
rebuild the balance of gut flora which can compete with
MRSA as rescue therapy. Subsequently truth from micro-
biota analysis told us that FMT did rectified the dysbiosis
of gut performing at a nearly normal abundant and diverse
as the donor and got an excellent curative effect.
Fig. 5 Staphylococcal Cassette Chromosome mec Genotype showed the strain of the acquired MRSA is SCC mec typeII as the amplification
length are all 398 bp
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Different from the other three Crohn’s patients, JYL was
not a patient with Crohn's disease and he is a 19 years boy
suffered from congenital intestinal malrotation and
Gastroptosis resulting in lots of gastric juice drainage
everyday and had been treated with broad-spectrum
antibiotic for two months before admitted to our centre,
so he himself maybe existed dysbiosis before surgery but
we didn’t notice that and MRSA breakout after operation.
Generally, antibiotic deplete the overall organism abun-
dance and can also lead to an increase in antibiotic resist-
ant organisms such as vancomycin-resistant enterococci,
methicillin-resistant Staphylococcus aureus and transfer of
antibiotic resistance genes among the microbial commu-
nity [11]. So FMT seems a more harmless and reasonable
measure to treat similar diseases.
However, we still couldn’t tell weather vancomycin or
the effective competition of transplanted intestinal flora
suppresses MRSA because patients accepted vancomycin
at the same time. But at least, we can well-founded finger
out that the intestinal flora restored no matter at abun-
dance or diversity and reached a new balance. At the same
time, we can see vancomycin did not kill transplanted
microbes in a short period of time, but long time effects
still needs further study.
Conclusions
Patients with hospital-acquired diarrhea of unknown
etiology, risk factors such as using broad-spectrum
antibiotic should alert the physician the possibility of
MRSA enteritis. Till now, vancomycin is the first choice
treating MSRA enteritis but we here suggest FMT as a
first-line measure to cure the dysbiosis coursed by MSRA.
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